Multiple immunological and platelet-regulatory pathways

The term Multiple immunological and platelet-regulatory pathways refers to a complex set of biological mechanisms rather than a single molecular target. It is frequently used in pharmacological databases to describe the pleiotropic effects of immunomodulatory therapies, most notably Intravenous Immunoglobulin (IVIG) and Anti-D immunoglobulin (https://www.ncbi.nlm.nih.gov/books/NBK554446/). These pathways involve the simultaneous modulation of several immune components, including the saturation of Fc gamma receptors (FcγR) on splenic macrophages to prevent the clearance of antibody-coated platelets, the neutralization of pathogenic autoantibodies by anti-idiotypic antibodies, and the inhibition of complement-mediated tissue damage (https://ashpublications.org/blood/article/120/26/5101/30841/How-intravenous-immunoglobulin-acts-in-immune). Additionally, these pathways encompass the modulation of cytokine networks and the expansion of regulatory T cells (Tregs) to restore immune tolerance (https://www.nature.com/articles/nrrheum.2013.11). Because clinical efficacy in conditions like Immune Thrombocytopenic Purpura (ITP) or Kawasaki disease is achieved through the integration of these diverse effects, the target is often classified under this broad descriptive heading.

Other names

Immunomodulatory pathwaysFc-receptor mediated pathwaysPlatelet-regulatory mechanismsIVIG mechanism pathways

Saturation of Fc gamma receptors (FcγR), neutralization of autoantibodies, modulation of cytokine networks, and suppression of complement activation.